MedTrace Logo

Metabolic FingerPrinting

NCT05305729 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2022-03-31

No results posted yet for this study

Summary

The MetaPrint study aims to characterize the metabolic fingerprint of genetic diseases in order to enhance knowledge on the physiological disease status and establish so new tools for diagnosing, monitoring and personalizing treatment of genetic diseases.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Arcensus GmbH

    lead INDUSTRY

Eligibility

Min Age
2 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • Albania
  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05305729 on ClinicalTrials.gov